ADDvise Group’s nomination committee for the Annual General Meeting 2022

08-10-2021   Regulatory press release

In accordance with the resolution at the 2021 annual general meeting of ADDvise Group AB, the nomination committee for the annual general meeting 2022 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register, which is maintained by Euroclear Sweden as of 30 June 2021, and the chairman of the board of directors acting as rapporteur. The representative appointed by the largest shareholder by votes shall be appointed chairman of the nomination committee.

The nomination committee has now been appointed and consists of the following members:

  • Per-Anders Tammerlöv (chairman of the nomination committee) appointed by Rikard Akhtarzand, shareholder through direct and indirect ownership
  • Per Åhlgren, shareholder through indirect ownership
  • Magnus Vahlquist, shareholder through direct and indirect ownership
  • Staffan Torstensson, chairman of ADDvise Group AB

The nomination committee shall prepare proposals for the 2022 annual general meeting regarding the appointment of chairman of the meeting, chairman of the board of directors, and other directors of the board and remuneration to the directors of the board and to the auditor.

Shareholders, who wish to present proposals to the nomination committee for the 2022 annual general meeting can submit them by post no later than 31 January 2022 to: ADDvise Group AB, att: Nomination Committee, Grev Turegatan 30, SE-114 38 Stockholm.

The Annual General Meeting 2022 in ADDvise Group AB will be held on the 6 May 2022.

For further information, please contact:

Hanna Myhrman, General Counsel
+46 709 82 92 23

hanna.myhrman@addvisegroup.se



About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.    

Latest press releases

ADDvise Group’s nomination committee for the Annual General Meeting 2022

Regulatory

In accordance with the resolution at the 2021 annual general meeting of ADDvise Group AB, the nomination committee for the annual general meeting 2022 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register, which is maintained by Euroclear Sweden as of 30 June 2021, and the chairman…

ADDvise Group’s reporting dates 2022

Regulatory

Year-End Report 2021 (Jan-Dec)                                 2022-02-24 Last day for shareholders to request                            2022-03-18 an item to be included to the agenda of the Annual General Meeting Interim Report (Jan-March 2022)                       …

On account of the difference in price movements in ADDvise Group’s shares

Regulatory

ADDvise Group AB (publ) (“ADDvise” and the “Company”) notes positive price movements in the Company's shares. ADDvise's share of series A carries one vote and share of series B carries one tenth of a vote, and besides this difference, the Company is not aware of any information concerning the Company which explains the difference between…

ADDvise updates long-term financial goals

Regulatory

ADDvise Group AB raises its long-term EBITDA financial target from 15% to 20%. ADDvise also raises its long-term revenue growth target from 20% to 25%. Other long-term financial goals remain unchanged. For the financial year 2022, on a pro forma basis rolling 12 months, ADDvise expects to reach revenue of SEK 1 billion with an…